MGH has been at the forefront of many scientific advances in treatments for depression.
Lior Hilsenrath is currently Clinical Assistant to Dr. Cristina Cusin, who is studying the use of ketamine for treatment-resistant depression. He is concurrently a research scientist at Boston Medical Center, where he is working together with the chief of neurosurgery, Dr. James Holsapple, to create a software technology that has the potential to assist patients who suffer traumatic brain injury. Lior obtained his B.S. degree in mathematics from the University of Maryland, College Park (UMD) in 2011. After continuing his graduate studies in statistics at his alma mater, Lior served a brief stint as a stockbroker on Wall Street. He then returned to UMD to serve as Lecturer on Mathematics. After caretaking for his ill mother, Lior decided to change his career path to medicine, so he completed Harvard University Extension School’s post-baccalaureate premedical program. He will begin medical school in the fall of 2019.